CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 84 enrolled
Drug / intervention
TAU - Phase 1 +4 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04728815
NCT04728815N/ACompleted

Comprehensive Adaptive Multisite Prevention of University Student Suicide (CAMPUS) - Feasibility Sub-Study

Duke University·interventional·Posted Jan 28, 2021·Updated Feb 29, 2024

In Brief

A clinical study evaluating TAU - Phase 1, CAMS - Phase 1, and 3 other interventions for Suicide. Completed, enrolled 84 participants across 4 sites.

Detailed Summary

Suicide is the 2nd leading cause of death among college students and suicidal ideation and suicide-related behaviors are a frequent presenting problem at college counseling centers (CCCs), which are overburdened. Studies show that some students respond rapidly to treatment, whereas others require considerably more resources. Evidence-based adaptive treatment strategies (ATSs) are needed to address this heterogeneity in responsivity and complexity. ATSs individualize treatment via decision rules specifying how the type and intensity of an intervention can be sequenced based on risk factors, response, or compliance. The purpose of this multisite study is to investigate the effectiveness of four adaptive treatment strategies (ATSs) to treat college students who report suicidal ideation when first seeking services at their college counseling center This multisite study will enroll moderately to severely suicidal college students in the "emerging adulthood" phase (ages 18-25) seeking services at CCCs. This Sequential Multi-Assignment Randomized Trial (SMART) will have two stages of intervention. In Stage 1, 700 participants from four CCCs will be randomized to 4-8 weeks of: 1) a suicide-focused treatment - Collaborative Assessment and Management of Suicidality (CAMS) or 2) Treatment as Usual (TAU). Sufficient responders to either intervention will discontinue services/be stepped down. Non-responders will be re-randomized to one of two Stage 2 higher intensity/dosage intervention options for an additional 4-16 weeks: 1) CAMS (either continued or administered for the first time) or 2) Comprehensive Dialectical Behavior Therapy (DBT), which includes individual therapy, skills group, and phone/text coaching for the clients and peer consultation for the counselors.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSuicide
CountriesUnited States

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJan 28, 2021
Enrollment StartJan 4, 2021
Primary CompletionOct 15, 2022
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 5.4 years ago

Interventions

TAU - Phase 1behavioral

4-8 weeks of TAU treatment

CAMS - Phase 1behavioral

4-8 weeks of CAMS treatment

DBT - Phase 1 and 2behavioral

up to 16 weeks of DBT treatment

CAMS - Phase 2behavioral

Up to 8 weeks of CAMS treatment

DBT - Phase 2behavioral

Up to 8 weeks of DBT treatment